Cerevel Therapeutics Holdings/ US15678U1280 /
2024-05-17 9:59:46 PM | Chg. -0.25 | Volume | Bid- | Ask- | High | Low |
---|---|---|---|---|---|---|
42.11USD | -0.58% | 37,412 Turnover: 1.58 mill. |
-Bid Size: - | -Ask Size: - | 42.30 | 42.10 |
GlobeNewswire
05-17
INVESTIGATION ANNOUNCEMENT: BFA Law Announces an Ongoing Investigation into the Merger between Cerev...
GlobeNewswire
05-14
CEREVEL THERAPEUTICS HOLDINGS, INC. (NASDAQ: CERE) INVESTIGATION ALERT: Is $45 per CERE Share Enough...
GlobeNewswire
05-10
Prime Medicine Reports First Quarter 2024 Financial Results and Provides Business Updates
GlobeNewswire
04-30
CEREVEL SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Cerevel Therapeutics Holdings,...
GlobeNewswire
04-18
Cerevel Therapeutics Announces Positive Topline Results for Tavapadon in Phase 3 Adjunctive Trial fo...
GlobeNewswire
01-29
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: McGrath Ren...
GlobeNewswire
01-04
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Icosavax, I...
GlobeNewswire
2023-12-27
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CERE, HOLI, ICVX, CVLY
GlobeNewswire
2023-12-27
ALERT: The M&A Class Action Firm Continues Investigating the Merger – BVH, HOLI, CERE, WAVD
GlobeNewswire
2023-12-26
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Icosavax, I...
GlobeNewswire
2023-12-18
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Alteryx, In...
GlobeNewswire
2023-12-14
STOCKHOLDER ALERT: Juan Monteverde Encourages the Shareholders of CERE, SRT, WAVD, GRPH to Take Acti...
GlobeNewswire
2023-12-11
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Consolidate...
GlobeNewswire
2023-12-08
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CERE, ROVR, SIX, BBAI
GlobeNewswire
2023-11-29
Cerevel Therapeutics to Host Investor Webcast on Tavapadon in Parkinson’s Disease
GlobeNewswire
2023-11-01
Cerevel Therapeutics Reports Third Quarter 2023 Financial Results and Business Updates
GlobeNewswire
2023-10-13
Cerevel Therapeutics to Report Third Quarter 2023 Financial Results and Business Updates on Wednesda...
GlobeNewswire
2023-10-12
Cerevel Therapeutics Announces Pricing of $450 Million Public Offering of Common Stock